Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Pharmacorp Clinical Trials
mi
from
Charleston, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Pharmacorp Clinical Trials
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Mountain View Clinical Research
mi
from
Greer, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Mountain View Clinical Research
mi
from
Greer, SC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Research Across America
mi
from
Northeast, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Research Across America
mi
from
Northeast, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Millenium Clinical Research Inc
mi
from
Houston, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Millenium Clinical Research Inc
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Renal Associates
mi
from
San Antonio, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Renal Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Cetero
mi
from
San Antonio, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Cetero
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
San Antonio Kidney Disease Center Physicians Group
mi
from
San Antonio, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
San Antonio Kidney Disease Center Physicians Group
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Multicare Research Institute (WA)
mi
from
Tacoma, WA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Multicare Research Institute (WA)
mi
from
Tacoma, WA
Click here to add this to my saved trials
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  3/30/2012
Clinical Research Facility
mi
from
Grand Island, NE
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 3/30/2012
Clinical Research Facility
mi
from
Grand Island, NE
Click here to add this to my saved trials
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  3/30/2012
Clinical Research Facility
mi
from
Dallas, TX
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 3/30/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  3/30/2012
Clinical Research Facility
mi
from
Houston, TX
Single Ascending Dose Trial in Patients With Type 2 Diabetes
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 3/30/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)
A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)
Status: Enrolling
Updated:  4/9/2012
Ahmanson-UCLA Cardiomyopathy Center
mi
from
Los Angeles, CA
A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)
A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)
Status: Enrolling
Updated: 4/9/2012
Ahmanson-UCLA Cardiomyopathy Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
African American Children, Glycemic Control, and Type 2 Diabetes
Vitamin D on Glycemic Control in African American Children With Type 2 Diabetes
Status: Enrolling
Updated:  4/13/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
African American Children, Glycemic Control, and Type 2 Diabetes
Vitamin D on Glycemic Control in African American Children With Type 2 Diabetes
Status: Enrolling
Updated: 4/13/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Outpatient Control-to-Range: System and Monitoring Testing
Outpatient Control-to-Range: System and Monitoring Testing
Status: Enrolling
Updated:  4/13/2012
University of Virginia
mi
from
Charlottesville, VA
Outpatient Control-to-Range: System and Monitoring Testing
Outpatient Control-to-Range: System and Monitoring Testing
Status: Enrolling
Updated: 4/13/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
Status: Enrolling
Updated:  4/17/2012
University of Chicago
mi
from
Chicago, IL
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
Status: Enrolling
Updated: 4/17/2012
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Early Intervention for Gestational Diabetes
Early Medical Intervention in Women at Risk for Gestational Diabetes
Status: Enrolling
Updated:  4/17/2012
Intermountain Medical Center
mi
from
Murray, UT
Early Intervention for Gestational Diabetes
Early Medical Intervention in Women at Risk for Gestational Diabetes
Status: Enrolling
Updated: 4/17/2012
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Maintaining Resistance Training in Older Prediabetic Adults
Maintaining Resistance Training in Older Prediabetic Adults: Theoretical Approach
Status: Enrolling
Updated:  4/18/2012
Virginia Tech
mi
from
Blacksburg, VA
Maintaining Resistance Training in Older Prediabetic Adults
Maintaining Resistance Training in Older Prediabetic Adults: Theoretical Approach
Status: Enrolling
Updated: 4/18/2012
Virginia Tech
mi
from
Blacksburg, VA
Click here to add this to my saved trials
Maintaining Resistance Training in Older Prediabetic Adults
Maintaining Resistance Training in Older Prediabetic Adults: Theoretical Approach
Status: Enrolling
Updated:  4/18/2012
VT Riverside
mi
from
Roanoke, VA
Maintaining Resistance Training in Older Prediabetic Adults
Maintaining Resistance Training in Older Prediabetic Adults: Theoretical Approach
Status: Enrolling
Updated: 4/18/2012
VT Riverside
mi
from
Roanoke, VA
Click here to add this to my saved trials
Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control
Impact of a Web-based Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control
Status: Enrolling
Updated:  4/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control
Impact of a Web-based Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control
Status: Enrolling
Updated: 4/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Effect of High Dose Folic Acid Versus Placebo on the Rate of Gestational Diabetes or Gestational Hypertension in Pregnant Women
The Effect of High Dose Folic Acid Versus Placebo on the Rate of Gestational Diabetes or Gestational Hypertension in Pregnant Women: a Randomized Controlled Trial.
Status: Enrolling
Updated:  4/19/2012
Mike O'Callaghan Federal Hospital
mi
from
Nellis AFB, NV
The Effect of High Dose Folic Acid Versus Placebo on the Rate of Gestational Diabetes or Gestational Hypertension in Pregnant Women
The Effect of High Dose Folic Acid Versus Placebo on the Rate of Gestational Diabetes or Gestational Hypertension in Pregnant Women: a Randomized Controlled Trial.
Status: Enrolling
Updated: 4/19/2012
Mike O'Callaghan Federal Hospital
mi
from
Nellis AFB, NV
Click here to add this to my saved trials
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
Status: Enrolling
Updated:  4/19/2012
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
mi
from
Las Vegas, NV
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
An Epidemiological Study of the Prevalence of Pre-Diabetes and Diabetes Among Air Force Personnel Who Fail the Air Force Physical Fitness Test at Nellis AFB, NV in 2011.
Status: Enrolling
Updated: 4/19/2012
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
A Preliminary Evaluation of the Safety and Pancreas Imaging Properties of 18F-AV-133 in Healthy Volunteers and in Patients With Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  4/19/2012
Clinical Research Facility
mi
from
Bronx, NY
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
A Preliminary Evaluation of the Safety and Pancreas Imaging Properties of 18F-AV-133 in Healthy Volunteers and in Patients With Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 4/19/2012
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Nancy J. Bohannon Med. Corp
mi
from
San Francisco, CA
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Nancy J. Bohannon Med. Corp
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Medsol Clinical Research Center
mi
from
Port Charlotte, FL
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Medsol Clinical Research Center
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Endocrine Research Solutions, Inc.
mi
from
Roswell, GA
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Endocrine Research Solutions, Inc.
mi
from
Roswell, GA
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
MidAmerica Diabetes Associates
mi
from
Wichita, KA
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
MidAmerica Diabetes Associates
mi
from
Wichita, KA
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
MODEL Clinical Research
mi
from
Baltimore, MD
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
MODEL Clinical Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Grunberger Diabetes Institute
mi
from
Bloomfield Hills, MI
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Grunberger Diabetes Institute
mi
from
Bloomfield Hills, MI
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
North Jersey Endocrine Consultants, LLCAND
mi
from
Denville, NJ
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
North Jersey Endocrine Consultants, LLCAND
mi
from
Denville, NJ
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Regional Endocrinology Associates, PC
mi
from
Santa Fe, NM
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Regional Endocrinology Associates, PC
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
North Shore Diabetes & Endocrine Assoc.
mi
from
New Hyde Park, NY
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
North Shore Diabetes & Endocrine Assoc.
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Endocrine Associates of Long Island, PC
mi
from
Smithtown, NY
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Endocrine Associates of Long Island, PC
mi
from
Smithtown, NY
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Middle Country Endocrinology, P.C.
mi
from
Smithtown, NY
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Middle Country Endocrinology, P.C.
mi
from
Smithtown, NY
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Physician's East
mi
from
Greenville, NC
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Physician's East
mi
from
Greenville, NC
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Down East Medical Associates
mi
from
Morehead City, NC
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Down East Medical Associates
mi
from
Morehead City, NC
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
Alan B. Schorr, DO FACE
mi
from
Langhorne, PA
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
Alan B. Schorr, DO FACE
mi
from
Langhorne, PA
Click here to add this to my saved trials
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated:  4/24/2012
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting: A Long-term, Prospective, Observational Registry (SIMPLE)
Status: Enrolling
Updated: 4/24/2012
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retina Consultants of Arizona
mi
from
Phoenix, AZ
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retina Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retina Vitreous Associates
mi
from
Beverly Hills, CA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retina Vitreous Associates
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Thomas A. Cuilla, MD, PC at Midwest Eye Institute
mi
from
Indianapolis, IN
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Thomas A. Cuilla, MD, PC at Midwest Eye Institute
mi
from
Indianapolis, IN
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Eyesight Ophthalmic Services, PA
mi
from
Portsmouth, NH
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Eyesight Ophthalmic Services, PA
mi
from
Portsmouth, NH
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retina Vitreous Center
mi
from
Toms River, NJ
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retina Vitreous Center
mi
from
Toms River, NJ
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Southeast Clinical Research Associates, LLC
mi
from
Charlotte, NC
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Southeast Clinical Research Associates, LLC
mi
from
Charlotte, NC
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Black Hills Regioinal Eye Institute
mi
from
Rapid City, SD
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Black Hills Regioinal Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated:  4/24/2012
Retinal Consultants of Houston
mi
from
Houston, TX
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)
Status: Enrolling
Updated: 4/24/2012
Retinal Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials